Addus HomeCare (ADUS) has drawn investor attention after recent trading, with the stock last closing at $111.92. The company’s performance across personal care, hospice, and home health services offers several data points to review.

The recent 1 month share price return of 16.47%, alongside a 3 year total shareholder return of 24.26%, points to improving momentum in Addus HomeCare as investors reassess its risk and growth profile.

If Addus HomeCare’s move has you thinking about what else could be on your radar, it might be a good time to check out 39 healthcare AI stocks.

After a 16.47% one-month jump and with the price still about 19% below the average analyst target and a larger indicated intrinsic discount, is the market rightly cautious on Addus HomeCare or mispricing its potential?

Most Popular Narrative: 15.7% Undervalued

At a last close of $111.92 against a narrative fair value of $132.69, Addus HomeCare is framed as undervalued, with that gap tied to its home based care model and acquisition track record.

Recent and upcoming state-level reimbursement rate increases in major markets (Illinois and Texas) are expected to add over $35 million in annualized revenue at stable 20%+ margins, directly supporting top-line growth and net margin expansion.

There is a detailed earnings roadmap behind that fair value, built on measured revenue growth, firmer margins, and a future profit multiple below many healthcare peers. Curious which specific forecast levers carry the most weight in that calculation and how they stack up over the next several years? The full narrative breaks those assumptions out line by line, so you can test whether they match your own expectations.

Result: Fair Value of $132.69 (UNDERVALUED)

However, investors in Addus HomeCare still need to weigh the impact of potential Medicare payment cuts, as well as its reliance on Medicaid and Medicare reimbursement in key states.

Next Steps

With Addus HomeCare framed as undervalued and some investors clearly optimistic, it could be worth checking the numbers yourself and deciding quickly where you stand. To see which potential upsides the market is focusing on right now, review the 4 key rewards.

Looking for more investment ideas beyond Addus HomeCare?

If Addus HomeCare has sharpened your focus, do not stop here. Use the Simply Wall St screener to spot other opportunities that fit your style.

• Target reliable compounding by zeroing in on companies that pass tough quality and value checks using the 38 high quality undervalued stocks.
• Prioritise resilience by focusing on businesses with robust finances and low leverage through the solid balance sheet and fundamentals stocks screener (48 results).
• Aim for hidden upside by scanning lesser known companies with strong fundamentals via the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.